Panser LA, Chute CG, Guess HA, Larsonkeller JJ, Girman CJ, Oesterling JE, et al. The natural history of prostatism: The effects of non-response bias. Int J Epidemiol. 1994;23:1198–205. https://doi.org/10.1093/ije/23.6.1198.
Article CAS PubMed Google Scholar
Cornu J, Gacci M, Hashim H, Herrmann T, Malde S, Netsch C, et al. EAU Guidelines on Non Neurogenic Male LUTS 2024. https://d56bochluxqnz.cloudfront.net/documents/full-guideline/EAU-Guidelines-on-Non-Neurogenic-Male-LUTS-2024.pdf. Accessed May 2024.
Nguyen ALV, Verma I, Ferreira R, Nguyen DD, Zorn KC, Bhojani N, et al. A scoping review of office-based prostatic stents: past, present, and future of true minimally invasive treatment of benign prostatic hyperplasia. World J Urol. 2023;41:2925–32. https://doi.org/10.1007/s00345-023-04508-7.
Ebbing J, Bachmann A. Anesthesia-free procedures for benign prostate obstruction: Worth it. Curr Opin Urol. 2015;25:32–9. https://doi.org/10.1097/MOU.0000000000000123.
Balakrishnan D, Jones P, Somani BK. iTIND: the second-generation temporary implantable nitinol device for minimally invasive treatment of benign prostatic hyperplasia. Ther Adv Urol. 2020;25:1756287220934355 https://doi.org/10.1177/1756287220934355.
Adam A, Jäger R, McLoughlin J, El-Din A, Machan L, Williams G, et al. Wallstent endoprostheses for the relief of prostatic urethral obstruction in high risk patients. Clin Radio. 1990;42:228–32. https://doi.org/10.1016/s0009-9260(05)82108-7.
Qiu CY, Wang JM, Zhang ZX, Huang ZX, Zheng QY, du ZQ, et al. Stent of Shape-Memory Alloy for Urethral Obstruction Caused by Benign Prostatic Hyperplasia. J Endourol. 1994;8:65–7. https://doi.org/10.1089/end.1994.8.65.
Article CAS PubMed Google Scholar
Song HY, Cho KS, Sung KB, Han YM, Kim YG, Kim CS. Self-expandable metallic stents in high-risk patients with benign prostatic hyperplasia: Long-term follow-up. Radiology. 1995;195:655–60. https://doi.org/10.1148/radiology.195.3.7538681.
Article CAS PubMed Google Scholar
Mori K, Okamoto S, Akimoto M. Placement of the Urethral Stent Made of Shape Memory Alloy in Management of Benign Prostatic Hypertrophy for Debilitated Patients. J Urol. 1995;154:1065–8.
Article CAS PubMed Google Scholar
Sun Y, Wang J, Li J, Zhang Y, Yao Y. Evaluation of a tubular mesh and a spiral stent woven from titanium nickel alloy for prostatic obstruction in patients at high risk for surgery. Report of 62 cases. Chin Med J (Engl) 1995;108:769–73.
Yip KH, Lee F, Lam PC, Ho KK. Urolume prostatic stents for urinary retention due to benign prostatic hyperplasia in patients with high medical risks. Hong Kong Med J 1997;3:136–40.
Traxer O, Anidjar M, Gaudez F, Saporta F, Daudon M, Cortesse A, et al. A new prostatic stent for the treatment of benign prostatic hyperplasia in high-risk patients. Eur Urol. 2000;38:272–8. https://doi.org/10.1159/000020293.
Article CAS PubMed Google Scholar
Perry MJA, Roodhouse AJ, Gidlow AB, Spicer TG, Ellis BW. Thermo-expandable intraprostatic stents in bladder outlet obstruction: An 8-year study. BJU Int. 2002;90:216–23. https://doi.org/10.1046/j.1464-410x.2002.02888.x.
Article CAS PubMed Google Scholar
Grimsley SJS, Khan MH, Lennox E, Paterson PH. Experience with the spanner prostatic stent in patients unfit for surgery: An observational study. J Endourol. 2007;21:1093–6. https://doi.org/10.1089/end.2006.0254.
Rouprêt M, Misraï V, De Fourmestraux A, Cour F, Richard F, Chartier-Kastler E. Clinical relevance of urethral stents (Urospiral 2TM) placement in patients with prostatic obstacle and concomitant high-risk surgical status or neurological diseases: A feasibility and safety study. Neurourol Urodyn. 2011;30:374–9. https://doi.org/10.1002/nau.20978.
Kim CS, Song HY, Jeong IG, Yeo HJ, Kim EY, Park JH, et al. Temporary placement of covered retrievable expandable nitinol stents with barbs in high-risk surgical patients with benign prostatic hyperplasia: Work in progress. J Vasc Inter Radio. 2011;22:1420–6. https://doi.org/10.1016/j.jvir.2011.06.017.
Bozkurt IH, Yalcinkaya F, Sertcelik MN, Zengin K, Ekici M, Yigitbasi O. A good alternative to indwelling catheter owing to benign prostate hyperplasia in elderly: Memotherm prostatic stent. Urology 2013;82:1004–7. https://doi.org/10.1016/j.urology.2013.07.004.
Schou-Jensen KS, Dahl C, Azawi NH. Prostate stent is an option for selected patients who are unsuitable for transurethral resection of the prostate. Dan Med J 2014;61:A4937.
Kimata R, Nemoto K, Tomita Y, Takahashi R, Hamasaki T, Kondo Y. Efficacy of a thermoexpandable metallic prostate stent (Memokath) in elderly patients with urethral obstruction requiring long-term management with urethral Foley catheters. Geriatr Gerontol Int. 2015;15:553–8. https://doi.org/10.1111/ggi.12309.
Yildiz G, Bahouth Z, Halachmi S, Meyer G, Nativ O, Moskovitz B. AlliumTM TPS - A New Prostatic Stent for the Treatment of Patients with Benign Prostatic Obstruction: The First Report. J Endourol. 2016;30:319–22. https://doi.org/10.1089/end.2015.0593.
Sethi K, Bozin M, Jabane T, McMullin R, Cook D, Forsyth R, et al. Thermo-expandable prostatic stents for bladder outlet obstruction in the frail and elderly population: An underutilized procedure. Investig Clin Urol. 2017;58:447–52. https://doi.org/10.4111/icu.2017.58.6.447.
Article PubMed PubMed Central Google Scholar
De Nunzio C, Cantiello F, Fiori C, Crocerossa F, Tognoni P, Amparore D, et al. Urinary and sexual function after treatment with temporary implantable nitinol device (iTind) in men with LUTS: 6-month interim results of the MT-06-study. World J Urol. 2020;39:2037–42. https://doi.org/10.1007/s00345-020-03418-2.
Article CAS PubMed Google Scholar
Chughtai B, Elterman D, Shore N, Gittleman M, Motola J, Pike S, et al. The iTind Temporarily Implanted Nitinol Device for the Treatment of Lower Urinary Tract Symptoms Secondary to Benign Prostatic Hyperplasia: A Multicenter, Randomized, Controlled Trial. Urology 2021;153:270–6. https://doi.org/10.1016/j.urology.2020.12.022.
Kaplan SA, Moss J, Freedman S, Coutinho K, Wu N, Efros M, et al. The PINNACLE Study: A Double-blind, Randomized, Sham-controlled Study Evaluating the Optilume BPH Catheter System for the Treatment of Lower Urinary Tract Symptoms Secondary to Benign Prostatic Hyperplasia. Urol. 2023;210:500–9. https://doi.org/10.1097/JU.0000000000003568.
Shah DK, Kapoor R, Badlani GH. Experience with urethral stent explantation. J Urol. 2003;169:1398–400. https://doi.org/10.1097/01.ju.0000049227.73112.3f.
Masood S, Djaladat H, Kouriefs C, Keen M, Palmer JH. The 12-year outcome analysis of an endourethral wallstent for treating benign prostatic hyperplasia. BJU Int. 2004;94:1271–4. https://doi.org/10.1111/j.1464-410X.2004.05155.x.
Oesterling JE, Kaplan SA, Epstein HB, Defalco AJ, Reddy PK, Chancellor MB. The North American experience with the UroLume endoprosthesis as a treatment for benign prostatic hyperplasia: long-term results. The North American UroLume Study Group. Urology. 1994;44:353–62. https://doi.org/10.1016/s0090-4295(94)80093-6.
Article CAS PubMed Google Scholar
Williams G, White R. Experience with the MemothermTM permanently implanted prostatic stent. Br J Urol. 1995;76:337–40. https://doi.org/10.1111/j.1464-410x.1995.tb07710.x.
Article CAS PubMed Google Scholar
Ricciotti G, Bozzo W, Perachino M, Pezzica C, Puppo P. Heat-Expansible Permanent Intraurethral Stents for Benign Prostatic Hyperplasia and Urethral Strictures. J Endourol. 1995;9:417–22. https://doi.org/10.1089/end.1995.9.417.
Article CAS PubMed Google Scholar
Dahlstrand C, Grundtman S, Pettersson S. High-energy transurethral microwave thermotherapy for large severely obstructing prostates and the use of biodegradable stents to avoid catheterization after treatment. Br J Urol. 1997;79:907–9. https://doi.org/10.1046/j.1464-410x.1997.00186.x.
Article CAS PubMed Google Scholar
Pétas A, Talja M, Tammela TLJ, Taari K, Välimaa T, Törmälä P. The biodegradable self-reinforced poiy-DL-lactic acid spiral stent compared with a suprapubic catheter in the treatment of post-operative urinary retention after visual laser ablation of the prostate. Br J Urol. 1997;80:439–43. https://doi.org/10.1046/j.1464-410x.1997.00308.x.
留言 (0)